» Articles » PMID: 22472858

HIV Reservoirs: Pathogenesis and Obstacles to Viral Eradication and Cure

Overview
Journal AIDS
Date 2012 Apr 5
PMID 22472858
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Plasma HIV viremia can be suppressed and maintained below the limits of detection for prolonged periods of time in the vast majority of HIV-infected individuals who receive antiretroviral therapy (ART). Thus, the clinical outcome for HIV-infected individuals who have access to these drugs is dramatically improved. However, ART alone cannot eradicate HIV in infected individuals and this impediment is likely in part due to the persistence of viral reservoirs in the peripheral blood and lymphoid tissues of infected individuals despite the suppression of plasma viremia. In recent years, major research efforts have been dedicated to a better understanding of the pathogenesis of persistent HIV infection and to the development of therapeutic strategies aimed at eradicating virus in infected individuals receiving ART. In this review, we discuss the pathophysiology of CD4 T-cell HIV reservoirs, including recent advances in our understanding of the mechanisms of persistent viral infection and perspectives for eradication of HIV in infected individuals.

Citing Articles

Cannabis Use in HIV: Impact on Inflammation, Immunity and the Microbiome.

Langat R, Chakrawarti A, Klatt N Curr HIV/AIDS Rep. 2025; 22(1):19.

PMID: 39984806 DOI: 10.1007/s11904-025-00729-0.


Bird's eye view of natural products for the development of new anti-HIV agents: Understanding from a therapeutic viewpoint.

Al Amin M, Nafady M, Zehravi M, Sweilam S, Kumar K, Akiful Haque M Animal Model Exp Med. 2025; 8(3):441-457.

PMID: 39921221 PMC: 11904116. DOI: 10.1002/ame2.12563.


Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management.

Nazari I, Feinstein M Clin Microbiol Rev. 2024; 37(1):e0009822.

PMID: 38299802 PMC: 10938901. DOI: 10.1128/cmr.00098-22.


Long-Term Effects of Incentives for HIV Viral Suppression: A Randomized Clinical Trial.

Novak M, Holtyn A, Toegel F, Rodewald A, Leoutsakos J, Fingerhood M AIDS Behav. 2023; 28(2):625-635.

PMID: 38117449 DOI: 10.1007/s10461-023-04249-z.


HIV-1 subtypes maintain distinctive physicochemical signatures in Nef domains associated with immunoregulation.

Lamers S, Fogel G, Liu E, Nolan D, Rose R, McGrath M Infect Genet Evol. 2023; 115:105514.

PMID: 37832752 PMC: 10842591. DOI: 10.1016/j.meegid.2023.105514.